GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Suven Life Sciences Ltd

Suven Life Sciences Allots 1.85 Cr Shares on Preferential Basis at Rs 134

MANAGEMENT ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 08 Jul 2026, 01:05 PM IST  ·  BSE ID: b7af9daf-9eba-4948-bb68-964f8d88e43b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company issued new shares at a set price to specific investors, converting warrants into ownership.
🤖 AI Summary
  • 1,85,70,133 equity shares allotted at Rs. 134 each on preferential basis.
  • Allotment is upon conversion of fully paid warrants to non-promoter entities.
  • Dr. Vajja Sambasiva Rao re-appointed as Director for a second five-year term.
  • The re-appointment is effective from January 21, 2027.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Allotted
1,85,70,133
Issue Price Per Share
Rs. 134/-
Face Value Per Share
Rs. 1/-
🏢 How This Affects the Company
💰
Financial Impact
The preferential allotment will increase the company's equity share capital and raise funds at a premium, strengthening its balance sheet.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding the allotment or re-appointment.
👤
Who Is Affected
All existing shareholders are affected by the issuance of 1,85,70,133 new equity shares, leading to potential dilution of their percentage ownership.
🔍
Management Signal
The preferential allotment signals management's intent to raise capital from specific investors at a determined valuation.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Updated shareholding pattern post allotment.
Announcement of utilization of funds raised from preferential issue.
Disclosure of director's responsibilities post re-appointment.
MEDIUM RISK Preferential allotment can lead to shareholding dilution and capital raises at potentially unfavorable valuations.
💡 Investor Takeaway
Suven Life Sciences allotted 1,85,70,133 equity shares at Rs. 134 each to non-promoters via warrant conversion, raising capital and potentially diluting existing holdings.
⚖️ Strengths & Concerns

✅ Positives

  • Raised capital at a premium of Rs. 133 per share (Rs. 134 issue price - Rs. 1 face value).

⚠️ Concerns

  • Dilution of existing shareholder equity due to the issuance of 1,85,70,133 new shares.
❓ Frequently Asked Questions
How many shares did Suven Life Sciences allot on preferential basis?
Suven Life Sciences allotted 1,85,70,133 equity shares on a preferential basis.
What was the issue price for the preferential allotment by Suven Life Sciences?
The issue price for the preferential allotment was Rs. 134 per equity share.
Who were the recipients of the preferential allotment by Suven Life Sciences?
The shares were allotted to non-promoter persons/entities upon conversion of fully paid warrants.
When is Dr. Vajja Sambasiva Rao's re-appointment effective?
Dr. Vajja Sambasiva Rao's re-appointment as Director is effective from January 21, 2027.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.